|
|
|
|
Vol. 17, Issue 3, 1075-1084, March 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







* Institute for Genetics and Center for Molecular Medicine, University of Cologne, D-50674 Cologne, Germany;
The Babraham Institute, Babraham, Cambridge CB2 4AT, United Kingdom;
|| Division of Neuroscience, University of Edinburgh, Edinburgh EH8 9JZ, United Kingdom;
¶ Avenir Team, INSERM U29, INMED, Luminy, 13273 Marseille Cedex 09, France; and
# Center for Biochemistry and Center for Molecular Medicine Cologne, University of Cologne, D-50931 Cologne, Germany
Submitted May 2, 2005;
Revised November 28, 2005;
Accepted December 2, 2005
Monitoring Editor: Jeffrey Brodsky
Slow Wallerian degeneration (WldS) mutant mice express a chimeric nuclear protein that protects sick or injured axons from degeneration. The C-terminal region, derived from NAD+ synthesizing enzyme Nmnat1, is reported to confer neuroprotection in vitro. However, an additional role for the N-terminal 70 amino acids (N70), derived from multiubiquitination factor Ube4b, has not been excluded. In wild-type Ube4b, N70 is part of a sequence essential for ubiquitination activity but its role is not understood. We report direct binding of N70 to valosin-containing protein (VCP; p97/Cdc48), a protein with diverse cellular roles including a pivotal role in the ubiquitin proteasome system. Interaction with WldS targets VCP to discrete intranuclear foci where ubiquitin epitopes can also accumulate. WldS lacking its N-terminal 16 amino acids (N16) neither binds nor redistributes VCP, but continues to accumulate in intranuclear foci, targeting its intrinsic NAD+ synthesis activity to these same foci. Wild-type Ube4b also requires N16 to bind VCP, despite a more C-terminal binding site in invertebrate orthologues. We conclude that N-terminal sequences of WldS protein influence the intranuclear location of both ubiquitin proteasome and NAD+ synthesis machinery and that an evolutionary recent sequence mediates binding of mammalian Ube4b to VCP.
Abbreviations used: DRG, dorsal root ganglion; ERAD, endoplasmic reticulum-associated protein degradation; IVTT, in vitro transcription and translation; N16, N-terminal 16 amino acids of WldS and Ube4b; N70, N-terminal 70 amino acids of WldS and Ube4b; Nmnat1, nicotinamide mononucleotide adenylyltransferase; Ube4b, ubiquitination factor E4b; Ufd2, ubiquitin fusion degradation protein 2; UPS, ubiquitin proteasome system; VCP, valosin-containing protein; WldS, slow Wallerian degeneration gene or protein.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).
These authors contributed equally to this work.
Present address: International University Bremen, D-28759 Bremen, Germany.
Address correspondence to: Michael P. Coleman (michael.coleman{at}bbsrc.ac.uk).
This article has been cited by other articles:
![]() |
T. M. Wishart, J. M. Paterson, D. M. Short, S. Meredith, K. A. Robertson, C. Sutherland, M. A. Cousin, M. B. Dutia, and T. H. Gillingwater Differential Proteomics Analysis of Synaptic Proteins Identifies Potential Cellular Targets and Protein Mediators of Synaptic Neuroprotection Conferred by the Slow Wallerian Degeneration (Wlds) Gene Mol. Cell. Proteomics, August 1, 2007; 6(8): 1318 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sasaki, T. Araki, and J. Milbrandt Stimulation of Nicotinamide Adenine Dinucleotide Biosynthetic Pathways Delays Axonal Degeneration after Axotomy. J. Neurosci., August 15, 2006; 26(33): 8484 - 8491. [Abstract] [Full Text] [PDF] |
||||